Investor
BIO-Europe
Europe's largest life science partnering conference, facilitating deals between biotechnology companies, pharmaceutical firms, and investment funds.
- When
- November, Early November
- Where
- RotatingView on Google Maps
- Format
- In person
- Organiser
- EBD Group
- Region
- Europe
- Scale
- About 5,000 attendees
- Founded
- 1995
The Signal
BIO-Europe is the largest life science partnering event in Europe, bringing together biotechnology developers, pharmaceutical companies, and private equity investors. The conference is highly focused on bilateral, pre-scheduled partnering meetings designed to broker licensing deals, research collaborations, and corporate investments. While it has a strong drug discovery focus, the event increasingly covers digital biomarkers, clinical trial technology, and companion diagnostics. It is a critical venue for healthtech operators targeting drug development workflows.
What to expect
- Biotechnology licensing and option agreements
- Corporate venture capital investment trends
- Pharmaceutical pipeline strategy announcements
- Clinical development partnership formations
Who is in the room
Biotechnology executives, pharmaceutical business development directors, venture capitalists, life science investment bankers, and academic tech transfer officers.
Background
Established by the EBD Group to meet the growing need for specialized business development tools in the European biotechnology sector, BIO-Europe has grown steadily. It is recognized as one of the key indicators of the health and volume of European life science transaction activity.
Related events
Running this event, or spotted something out of date?